Wenzhan Yang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Venues

Nature communications

The AAPS journal

Pharmaceutical research

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenzhan Yang, Steve Cook, Dedong Wu
Pre-clinical Formulation Development of an in situ Meglumine Salt of AZD5991: A Novel Macrocyclic Mcl-1 Inhibitor. Pharmaceutical research (2023)
Divya Sharma, Faraj Atassi, Steve Cook, Stacey Marden, Jianyan Wang, Aixiang Xue, David J Wagner, Guangnong Zhang, Wenzhan Yang
Experimental design, development and evaluation of extended release subcutaneous thermo-responsive in situ gels for small molecules in drug discovery. Pharmaceutical development and technology 26 (10) (2021)
Wenzhan Yang, Prajakta Gadgil, Venkata R Krishnamurthy, Margaret Landis, Pankajini Mallick, Dipal Patel, Phenil J Patel, Darren L Reid, Manuel Sanchez-Felix
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules. The AAPS journal 22 (2) (2020)
Adriana E Tron, Matthew A Belmonte, Ammar Adam, Brian M Aquila, Lawrence H Boise, Elisabetta Chiarparin, Justin Cidado, Kevin J Embrey, Eric Gangl, Francis D Gibbons, Gareth Peter Gregory, David Hargreaves, J Adam Hendricks, Jeffrey W Johannes, Ricky W Johnstone, Steven L Kazmirski, Jason G Kettle, Michelle L Lamb, Shannon M Matulis, Ajay K Nooka, Martin J Packer, Bo Peng, Philip B Rawlins, Daniel W Robbins, Alwin G Schuller, Nancy Su, Wenzhan Yang, Qing Ye, Xiaolan Zheng, J Paul Secrist, Edwin A Clark, David M Wilson, Stephen E Fawell, Alexander W Hird
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nature communications 9 (1) (2018)

Wenzhan Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wenzhan Yang